RxDoctor Payments Data

Lisa Candelaria

Family · Rio Rancho, NMNPI 1649671918

Payments from drug & device makers

$303in general payments, 2019–2025

Across 13 payments — averaging $23.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insulet Corporation$89
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$56
  • Lilly USA, LLC$34
  • Neurocrine Biosciences, Inc.$29
  • Abbott$21
  • Astellas Pharma US Inc$19
  • plus $54 from 3 others

What the payments were for

  • Food & beverage$303100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$303 in reported general payments places this provider in the 55th percentile of 1,080 family providers in New Mexico.

See all family providers in New Mexico

Medicare billing

Part B allowed, 2024
$336
Medicare patients
29
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium15$226
Lisinopril11$117
Levothyroxine Sodium11$91

Paid to pharmacies, not to this prescriber.

Other family in Rio Rancho

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →